@misc{indiciae663e82c15636,
  title = {Trastuzumab deruxtecan plus pertuzumab in first-line HER2-positive advanced/metastatic breast cancer.},
  author = {Sara M Tolaney and Sibylle Loibl},
  year = {2026},
  doi = {10.21037/tcr-2026-1671},
  url = {https://pubmed.ncbi.nlm.nih.gov/42724828/},
  note = {Source identifier: 42724828}
}